Teva To Double Japan Drug-Making Capacity With $203 Million Surge
This article was originally published in PharmAsia News
Executive Summary
Teva Pharmaceutical Industries plans a $203 million expansion of its production facilities in Japan to make the nation a major manufacturing base with a 9 billion pills-per-year capacity by 2018.